HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Upregulation of fatty acid synthase gene expression in experimental chronic renal failure.

Abstract
Hypertriglyceridemia associated with chronic renal failure (CRF) and elevated plasma concentration of very-low-density lipoprotein (VLDL) are thought to be a consequence of the depressed lipoprotein lipase and hepatic lipase activities and impaired clearance of lipoproteins. However, there is some evidence that the lipoproteins overproduction might also contribute to hypertriglyceridemia in CRF. This study was performed to test the hypothesis that the increased rate of lipogenesis consequent to upregulation of fatty acid synthase (FAS), a key lipogenic enzyme, gene expression could contribute to overproduction of triacylglycerols and to hypertriglyceridemia in CRF. FAS activity, FAS protein mass (Western blot analysis), and FAS mRNA level (Northern blot analysis) in liver and epididymal white adipose tissue (WAT) were measured in male Wistar rats 6 weeks after subtotal (5 of 6) nephrectomy or sham operation. Moreover, the rate of lipogenesis in WAT was determined. The CRF group showed significant increase in FAS gene expression (measured as activity, mRNA, and protein abundance) in both liver and WAT. This was associated with the increase in the lipogenesis rate and with the increase in plasma triacylglycerol and VLDL concentrations. Our results suggest that not only decreased removal, but also an increase of triacylglycerol production could contribute, in part, to the CRF-associated hyperlipidemia. Upregulation of FAS gene expression, shown in this report for the first time, reveals another factor involved in disturbed lipid metabolism in CRF. It seems that elevated plasma insulin and cytokine concentration could play an important role in the mechanism responsible for the increased FAS gene expression in CRF.
AuthorsMarek Szolkiewicz, Tomasz Nieweglowski, Justyna Korczynska, Elzbieta Sucajtys, Ewa Stelmanska, Elzbieta Goyke, Julian Swierczynski, Boleslaw Rutkowski
JournalMetabolism: clinical and experimental (Metabolism) Vol. 51 Issue 12 Pg. 1605-10 (Dec 2002) ISSN: 0026-0495 [Print] United States
PMID12489075 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright 2002, Elsevier Science (USA). All rights reserved.
Chemical References
  • Lipids
  • Lipoproteins, VLDL
  • RNA, Messenger
  • Triglycerides
  • Fatty Acid Synthases
Topics
  • Adipose Tissue (metabolism)
  • Animals
  • Epididymis
  • Fatty Acid Synthases (genetics)
  • Gene Expression
  • Kidney Failure, Chronic (genetics, metabolism, physiopathology)
  • Lipids (biosynthesis)
  • Lipoproteins, VLDL (blood)
  • Liver (metabolism)
  • Male
  • Nephrectomy (methods)
  • RNA, Messenger (metabolism)
  • Rats
  • Rats, Wistar
  • Triglycerides (blood)
  • Up-Regulation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: